TWI350174B - Adjuvanted bovine vaccines - Google Patents

Adjuvanted bovine vaccines

Info

Publication number
TWI350174B
TWI350174B TW093105710A TW93105710A TWI350174B TW I350174 B TWI350174 B TW I350174B TW 093105710 A TW093105710 A TW 093105710A TW 93105710 A TW93105710 A TW 93105710A TW I350174 B TWI350174 B TW I350174B
Authority
TW
Taiwan
Prior art keywords
adjuvanted
bovine vaccines
vaccines
bovine
adjuvanted bovine
Prior art date
Application number
TW093105710A
Other languages
English (en)
Other versions
TW200423956A (en
Inventor
Hsien-Jue Chu
Wumin Li
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of TW200423956A publication Critical patent/TW200423956A/zh
Application granted granted Critical
Publication of TWI350174B publication Critical patent/TWI350174B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
TW093105710A 2003-03-12 2004-03-04 Adjuvanted bovine vaccines TWI350174B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45418203P 2003-03-12 2003-03-12

Publications (2)

Publication Number Publication Date
TW200423956A TW200423956A (en) 2004-11-16
TWI350174B true TWI350174B (en) 2011-10-11

Family

ID=32990880

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093105710A TWI350174B (en) 2003-03-12 2004-03-04 Adjuvanted bovine vaccines

Country Status (12)

Country Link
US (1) US20040180060A1 (zh)
EP (1) EP1601375A2 (zh)
JP (1) JP2006519880A (zh)
AR (1) AR043539A1 (zh)
AU (2) AU2004220543A1 (zh)
BR (1) BRPI0408249A (zh)
CA (1) CA2517498A1 (zh)
CO (1) CO5660272A2 (zh)
MX (1) MXPA05009447A (zh)
NZ (1) NZ542253A (zh)
TW (1) TWI350174B (zh)
WO (1) WO2004080400A2 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8758771B2 (en) 2003-10-31 2014-06-24 The University Of British Columbia Bacterial virulence factors and uses thereof
AU2008324780A1 (en) 2007-11-06 2009-05-14 Pah W Llc Mycoplasma hyopneumoniae avirulent -adjuvanted live vaccine
EP2485725A2 (en) * 2009-10-07 2012-08-15 Wyeth LLC Compositions comprising adjuvant, macrolide and proteinaceous antigen and methods of use thereof
JPWO2012157699A1 (ja) * 2011-05-18 2014-07-31 味の素株式会社 動物用免疫賦活剤、それを含む飼料及びその製造方法
WO2015042369A2 (en) * 2013-09-19 2015-03-26 Zoetis Llc Oil-based adjuvants

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0827028A (ja) * 1994-07-21 1996-01-30 Nippon Seibutsu Kagaku Kenkyusho 油性アジュバント及びアルミニウムゲルアジュバントからなる動物用ワクチン製剤
US5730989A (en) * 1995-02-16 1998-03-24 Novavax, Inc. Oral vaccine against gram negative bacterial infection
US5976580A (en) * 1995-06-07 1999-11-02 Novus International, Inc. Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals
US5965128A (en) * 1997-08-13 1999-10-12 University Of Georgia Research Foundation Inc. Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli
JP4282804B2 (ja) * 1998-12-24 2009-06-24 新日本石油株式会社 アジュバント組成物
WO2000051634A1 (fr) * 1999-03-03 2000-09-08 The Kitasato Institute Preparations de vaccins contenant des acides gras comme composants
GB9923176D0 (en) * 1999-09-30 1999-12-01 Smithkline Beecham Biolog Novel composition
JP2001131087A (ja) * 1999-11-05 2001-05-15 Chemo Sero Therapeut Res Inst オイルアジュバントワクチン
JP2003515340A (ja) * 1999-11-29 2003-05-07 アクゾ・ノベル・エヌ・ベー マイコプラズマ・ミコイデス亜種ミコイデスＳＣの抗原性タンパク質ＬｐｐＱ、その調製および使用
US6162441A (en) * 1999-12-15 2000-12-19 Republic Of Korea (Management: Rural Development Administration) Method for the production of anti-escherichia. coli O157 : H7 antibody
AUPQ761200A0 (en) * 2000-05-19 2000-06-15 Hunter Immunology Limited Compositions and methods for treatment of mucosal infections
CA2420601A1 (en) * 2000-08-31 2003-02-26 The Kitasato Institute Vaccine preparation containing fatty acid as component
BR0206312A (pt) * 2001-01-04 2004-02-17 Univ Saskatchewan Composição de vacina, uso sobrenadante de cultura celular de escherichia coli enteroemorrágica (ehec), e, métodos para a geração de uma resposta imunológica em um mamìfero contra um antìgeno de escherichia coli enteroemorrágica (ehec) secretado, e 0157:h7 enteroemorrágica (ehec 0157:h7) secretado, e para a redução da colonização de escherichia coli enteroemorrágica (ehec) em um ruminante
CA2437899C (en) * 2001-02-13 2012-05-15 Gregory M. Glenn Vaccine for transcutaneous immunization against etec-caused traveler's diarrhea
EP1314359A1 (en) * 2001-11-21 2003-05-28 N.V. Seghers Nutrition Sciences Growth promoter composition for animals

Also Published As

Publication number Publication date
AR043539A1 (es) 2005-08-03
CO5660272A2 (es) 2006-07-31
US20040180060A1 (en) 2004-09-16
WO2004080400A3 (en) 2005-03-03
AU2010202344A1 (en) 2010-07-01
TW200423956A (en) 2004-11-16
EP1601375A2 (en) 2005-12-07
BRPI0408249A (pt) 2006-03-01
AU2004220543A1 (en) 2004-09-23
JP2006519880A (ja) 2006-08-31
NZ542253A (en) 2008-07-31
WO2004080400A2 (en) 2004-09-23
MXPA05009447A (es) 2005-11-23
CA2517498A1 (en) 2004-09-23

Similar Documents

Publication Publication Date Title
IL223457A0 (en) Flavivirus vaccines
IL173921A0 (en) Vaccine
GB0329146D0 (en) Vaccine
GB0225786D0 (en) Vaccine
GB0212046D0 (en) Vaccines
GB0323840D0 (en) Vaccines
GB0305794D0 (en) Vaccine
TWI350174B (en) Adjuvanted bovine vaccines
GB0330079D0 (en) Vaccine
GB0209878D0 (en) Vaccine
GB0321614D0 (en) Vaccines
GB0305793D0 (en) Vaccine
GB0304634D0 (en) Vaccines
GB0212036D0 (en) Vaccines
GB0206595D0 (en) Vaccine
GB0330007D0 (en) Vaccines
GB0223355D0 (en) Vaccine
GB0300397D0 (en) Vaccines
GB0300914D0 (en) Vaccines
GB0304635D0 (en) Vaccines
GB0304672D0 (en) Vaccines
GB0327885D0 (en) Vaccine
GB0329827D0 (en) Vaccine
GB0305028D0 (en) Vaccine
GB0326757D0 (en) Vaccine

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees